COA 2023: Novel Cementless Hydroxyapatite-Coated Hip Stem in Total Hip Arthroplasty .
Randomized controlled trial comparison of two hydroxyapatite coated hip stems using radiostereometric analysis
46 patients scheduled for a total hip arthroplasty were randomized to receive an existing cementless hydroxyapatite coated stem or a novel cementless hydroxyapatite coated stem with increased coating and a blended compaction extraction femoral broach. The primary outcome of interest was stem migration, as measured by radiostereometric analysis imaging for subsidence, tilt, anteversion-retroversion, and maximum total point motion. Patient-reported outcome measures for function, quality of life, and pain were also measured, as well as duration of walking aid use. Outcomes were assessed up to 24 months post-operation. Whilst both groups demonstrated improvement from pre-surgery levels, no differences in all outcomes were observed between the two groups suggesting that existing hydroxyapatite-coated stems provide comparable clinical outcomes to the novel stem with additional coating.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics